Information
-
Trademark
-
79225147
-
Serial Number
79225147
-
Registration Number
6630735
-
International Classifications
-
Filing Date
October 11, 2017
7 years ago
-
Registration Date
February 01, 2022
2 years ago
-
Transaction Date
August 01, 2022
2 years ago
-
Status Date
February 01, 2022
2 years ago
-
Published for Opposition Date
November 16, 2021
3 years ago
-
Location Date
February 01, 2022
2 years ago
-
Status Code
700
-
Current Location
PUBLICATION AND ISSUE SECTION
Employee Name
SHOOR, AMIT KUMAR
-
Attorney Docket Number
tbd
Attorney Name
Eric T. Fingerhut
Law Office Assigned Location Code
M80
-
Owners
Mark Drawing Code
3000
Mark Identification
ASCENDIS PHARMA
Case File Statements
- DM0000: The mark consists of the turquoise word "ASCENDIS" under which is the grey word "PHARMA" next to a polygon broken by a white curved band in which the top is turquoise and the bottom is blue.
- GS0051: Pharmaceutical and veterinary preparations for the treatment of physical and mental illness, namely, pharmaceutical preparations for use in enzyme replacement therapy; pharmaceutical and veterinary preparations, namely, vaccines for the treatment of physical and mental illness; pharmaceutical and veterinary preparations for the treatment of physical and mental illness, namely, pharmaceutical preparations for the prevention and treatment of disorders of the endocrine system, growth hormone deficiencies, hypoparathyroidism, achondroplasia, diabetes, fibroblast growth factor receptor(FGFR)-related skeletal disorders, oncological disorders, ophthalmologic disorders, infectious diseases, enzyme replacement therapy, anti-inflammatory diseases, pain, respiratory system disorders, autoimmune disorders, vaccines, non-alcoholic steatohepatitis, brain diseases, bone diseases, CNS diseases, myopathies, obesity, wounds healing, the hormonal system disorders, namely, growth hormone deficiencies, diabetes and angiogenesis, the ophthalmological system disorders, namely, angiogenesis, the angiogenic system disorders, the central nervous system disorders, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, the immune system disorders, namely, immunologic diseases, namely, autoimmune diseases and immunologic deficiency syndromes, the cardio-vascular system diseases, the metabolic system disorders, namely, diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, the respiratory system, the musculo-skeletal system disorders, namely, growth hormone deficiencies, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, the genitourinary system disorders, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of inflammatory disorders, namely, anti-inflammatories; pharmaceutical preparations for use in dermatology, namely, dermatitis, eczema, psoriasis; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in hematology; pharmaceutical preparations for use in tissue and organ transplantation; pharmaceutical preparations for use in in ophthalmology pharmaceutical preparations for use in the treatment of gastroenterological disorders; sanitary preparations for medical purposes, namely, sanitizing wipes, disinfectants for medical instruments, adhesive tapes for medical purposes, dietetic foods, namely, dietetic sugar substitutes adapted for medical use, all-purpose disinfectants for sanitary purposes; fungicides, herbicides
- CC0000: The color(s) turquoise, grey, white and blue is/are claimed as a feature of the mark.
- GS0451: Licensing of industrial property; legal services
- D10000: "PHARMA"
- GS0421: Scientific research within the medical, pharmaceutical and bacteriological area and providing scientific consultancy and information in relation to the aforementioned scientific research, conducting of tests regarding medical applications, namely, conducting clinical trials for others, packaging design, designing and development of medical equipment, designing pharmaceutical and medical preparations, preparation of pharmaceutical formulations, namely, pharmaceutical products development, design and development of granulation technology and tablet technology and providing scientific consultancy and information relating to the design and development of granulation technology and tablet technology
Case File Event Statements
-
8/1/2022 - 2 years ago
73 - FINAL DECISION TRANSACTION PROCESSED BY IB
Type: FINO
-
7/13/2022 - 2 years ago
72 - FINAL DISPOSITION NOTICE SENT TO IB
Type: FICS
-
7/13/2022 - 2 years ago
71 - FINAL DISPOSITION PROCESSED
Type: FIMP
-
5/1/2022 - 2 years ago
70 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Type: FICR
-
2/1/2022 - 2 years ago
69 - REGISTERED-PRINCIPAL REGISTER
Type: R.PR
-
12/24/2021 - 3 years ago
68 - NEW REPRESENTATIVE AT IB RECEIVED
Type: NREP
-
11/23/2021 - 3 years ago
67 - NOTIFICATION PROCESSED BY IB
Type: GPNX
-
11/16/2021 - 3 years ago
66 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Type: NPUB
-
11/16/2021 - 3 years ago
65 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
10/28/2021 - 3 years ago
64 - NEW REPRESENTATIVE AT IB RECEIVED
Type: NREP
-
10/27/2021 - 3 years ago
63 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Type: OPNS
-
10/27/2021 - 3 years ago
62 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Type: OP2R
-
10/27/2021 - 3 years ago
61 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Type: NONP
-
10/13/2021 - 3 years ago
60 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
10/12/2021 - 3 years ago
59 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
10/12/2021 - 3 years ago
58 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
10/12/2021 - 3 years ago
57 - TEAS REQUEST FOR RECONSIDERATION RECEIVED
Type: ERFR
-
7/9/2021 - 3 years ago
56 - NOTIFICATION OF FINAL REFUSAL EMAILED
Type: GNFN
-
7/9/2021 - 3 years ago
55 - FINAL REFUSAL E-MAILED
Type: GNFR
-
7/9/2021 - 3 years ago
54 - FINAL REFUSAL WRITTEN
Type: CNFR
-
6/10/2021 - 3 years ago
53 - ASSIGNED TO EXAMINER
Type: DOCK
-
3/16/2021 - 3 years ago
52 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
3/15/2021 - 3 years ago
51 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
3/15/2021 - 3 years ago
50 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
3/15/2021 - 3 years ago
49 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Type: CHAN
-
3/15/2021 - 3 years ago
48 - TEAS CHANGE OF CORRESPONDENCE RECEIVED
Type: TCCA
-
3/15/2021 - 3 years ago
47 - TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Type: ECDR
-
3/15/2021 - 3 years ago
46 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Type: ARAA
-
3/15/2021 - 3 years ago
45 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Type: REAP
-
3/15/2021 - 3 years ago
44 - TEAS CHANGE OF OWNER ADDRESS RECEIVED
Type: COAR
-
3/15/2021 - 3 years ago
43 - TEAS CHANGE OF CORRESPONDENCE RECEIVED
Type: TCCA
-
3/15/2021 - 3 years ago
42 - TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Type: EWOR
-
3/15/2021 - 3 years ago
41 - TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Type: EWAF
-
3/15/2021 - 3 years ago
40 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Type: ARAA
-
3/15/2021 - 3 years ago
39 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Type: REAP
-
9/14/2020 - 4 years ago
38 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
9/14/2020 - 4 years ago
37 - NON-FINAL ACTION E-MAILED
Type: GNRT
-
9/14/2020 - 4 years ago
36 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
6/18/2020 - 4 years ago
35 - SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Type: RCCK
-
6/3/2020 - 4 years ago
34 - ASSIGNED TO LIE
Type: ALIE
-
11/21/2019 - 5 years ago
33 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Type: RCSC
-
7/5/2019 - 5 years ago
32 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Type: OPNX
-
6/19/2019 - 5 years ago
31 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Type: OPNS
-
6/19/2019 - 5 years ago
30 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Type: OPNR
-
5/9/2019 - 5 years ago
29 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Type: RCSC
-
10/19/2018 - 6 years ago
28 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Type: GNS3
-
10/19/2018 - 6 years ago
27 - LETTER OF SUSPENSION E-MAILED
Type: GNSL
-
10/19/2018 - 6 years ago
26 - SUSPENSION LETTER WRITTEN
Type: CNSL
-
10/1/2018 - 6 years ago
25 - DATA MODIFICATION COMPLETED
Type: DMCC
-
9/28/2018 - 6 years ago
24 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
9/27/2018 - 6 years ago
23 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
9/27/2018 - 6 years ago
22 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
9/14/2018 - 6 years ago
21 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
9/14/2018 - 6 years ago
20 - NON-FINAL ACTION E-MAILED
Type: GNRT
-
9/14/2018 - 6 years ago
19 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
8/17/2018 - 6 years ago
18 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
8/17/2018 - 6 years ago
17 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
8/16/2018 - 6 years ago
16 - ASSIGNED TO LIE
Type: ALIE
-
7/26/2018 - 6 years ago
15 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
7/24/2018 - 6 years ago
14 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Type: ARAA
-
7/24/2018 - 6 years ago
13 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Type: REAP
-
3/2/2018 - 6 years ago
12 - REFUSAL PROCESSED BY IB
Type: RFNT
-
2/9/2018 - 6 years ago
11 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Type: RFCS
-
2/9/2018 - 6 years ago
10 - REFUSAL PROCESSED BY MPU
Type: RFRR
-
2/7/2018 - 6 years ago
9 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Type: RFCR
-
2/6/2018 - 6 years ago
8 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
2/2/2018 - 6 years ago
7 - NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Type: RFWR
-
1/30/2018 - 6 years ago
6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Type: RFCR
-
1/29/2018 - 6 years ago
5 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
1/23/2018 - 6 years ago
4 - APPLICATION FILING RECEIPT MAILED
Type: MAFR
-
1/19/2018 - 6 years ago
3 - ASSIGNED TO EXAMINER
Type: DOCK
-
1/19/2018 - 6 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Type: NWOS
-
1/18/2018 - 6 years ago
1 - SN ASSIGNED FOR SECT 66A APPL FROM IB
Type: REPR